ANTHEM — Anthem Biosciences Cashflow Statement
0.000.00%
- IN₹528.00bn
- IN₹518.42bn
- IN₹21.24bn
Annual cashflow statement for Anthem Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | R2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5,461 | 4,973 | 4,773 | 6,569 | 8,242 |
| Depreciation | |||||
| Non-Cash Items | -91.6 | -365 | -370 | -160 | -492 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2,619 | -2,186 | -3,820 | -4,597 | -646 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3,329 | 3,060 | 1,402 | 2,706 | 8,445 |
| Capital Expenditures | -1,576 | -1,889 | -2,963 | -2,656 | -2,112 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -479 | -1,871 | 749 | 1,190 | -4,905 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2,055 | -3,760 | -2,215 | -1,466 | -7,016 |
| Financing Cash Flow Items | -23 | -256 | -357 | -97.9 | -68.8 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,807 | 640 | -772 | -1,356 | -400 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3,081 | -60.6 | -1,585 | -121 | 1,026 |